NEWS /

OPINION /

Q&A

Conversations with experts about noteworthy topics in autism.

Previous articles

June 2015
b20150616qaarineemanart
Opinion / Q&A

Questions for Ari Ne’eman: Partnering with participants

by  /  16 June 2015

Autistic adults should be partners in the research process, not just ‘subjects’ in a study, says Ari Ne’eman.

44 Comments
20150602qadurkin
Opinion / Q&A

Questions for Maureen Durkin: Understanding autism’s rise

by  /  2 June 2015

Autism is undoubtedly on the rise, but we may never be able to fully explain why, says Maureen Durkin.
 

6 Comments
May 2015
Lost in translation: Lowering the levels of a complex that stalls protein synthesis prompts stems cells (green, left panel) to mature into neurons (blue, right panel) in the embryonic mouse brain.
Opinion / Q&A

Questions for Miller, Kaplan: New neurons’ role in autism

by  /  12 May 2015

An autism-linked gene controls the number of neurons in the developing brain. Freda Miller and David Kaplan say the finding points to a new role for the gene in the early embryo.

0 Comments
April 2015
a20150428qarauen
Opinion / Q&A

Questions for Katherine Rauen: Cancer pathway’s autism link

by  /  28 April 2015

Clinicians saw autism signs in children with mutations in a cancer pathway long before sequencing studies made the connection, says Katherine Rauen.

1 Comment
20150414qalarryyoung
Opinion / Q&A

Questions for Larry Young: Oxytocin’s promise for autism

by  /  14 April 2015

Understanding how oxytocin works in the brain will help researchers cut through the hype surrounding the infamous ‘love hormone’ and translate it into a treatment for autism, says Larry Young.

3 Comments
March 2015
20150331klannqa
Opinion / Q&A

Questions for Eric Klann: Translating treatments for fragile X

by  /  30 March 2015

Treatments for fragile X syndrome may be more successful if they block direct targets of the key missing protein, says Eric Klann.

0 Comments
b20150303qafein
Opinion / Q&A

Questions for Deborah Fein: Defining ‘optimal outcome’

by  /  3 March 2015

Understanding why some children appear to outgrow their autism diagnosis may provide clues about the biology of the disorder but shouldn’t dictate treatment decisions, says Deborah Fein.

6 Comments
February 2015
20150217qamainkravis
Opinion / Q&A

Questions for Elizabeth Berry-Kravis: Measuring drug effects

by  /  17 February 2015

Drugs designed to treat fragile X syndrome have yet to show substantial benefits in people. But rather than abandon them, child neurologist Elizabeth Berry-Kravis suggests a new way to measure their effectiveness.

3 Comments
January 2015
c20150120qamandell
Opinion / Q&A

Questions for David Mandell: Curbing autism’s costs

by  /  20 January 2015

Existing autism therapies do little to lower the lifetime costs of having the disorder, so clinicians should consider more efficient and inexpensive alternatives, says David Mandell.

5 Comments
20150102qaericlondonillo
Opinion / Q&A

Questions for Eric London: Alternative diagnoses for autism

by  /  2 January 2015

Names such as autism, schizophrenia and intellectual disability are ‘umbrella’ terms that muddy the search for the true cause of an individual’s symptoms, says Eric London. He plans to come up with an alternative diagnostic scheme for developmental disabilities over the next two years.

8 Comments

Browse Articles by Topic

  • Genes
    Genes
  • The Brain
    The Brain
  • Diagnosis
    Diagnosis
  • Signs and Symptoms
    Signs & Symptoms
  • Treatments
    Treatments
  • Environment
    Environment
  • Science and Society
    Science & Society
close

Log in to your Spectrum Wiki account

Email Address:

Password:


close

Request your Spectrum Wiki account

Spectrum Wiki is a community of researchers affiliated with an academic or research institutions. To be considered for participation, please fill out this form and a member of our team will respond to your request.

Name:

Email Address:

Title and Lab:

Area of Expertise:

Comments: